PHASE III MEDICAL INC/DE

PHASE III MEDICAL INC/DE insiders are currently net buyers of PHSM stock, showing neutral sentiment over the past 90 days. Executives have purchased $30.0K while selling $18.0K, resulting in a positive net flow of $12.0K. This buying activity represents 63% of total transaction volume.

PHASE III MEDICAL INC/DE has 7 active insiders who have filed SEC Form 4 transactions in the past 90 days. Robin L. Smith (Executive) leads with 6 transactions totaling $38.8K. Jr Family Trust Aholt (Executive) follows with 1 transactions worth $18.0K. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.

The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. PHASE III MEDICAL INC/DE's current score of 63/100 indicates neutral insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $30.0K in purchases versus $18.0K in sales.

The most recent insider transaction occurred on Aug 30, 2006, when M. Vaczy Catherine (Executive) disposed of 284,090 shares at $0.04 per share for $11.4K. This appears to be a discretionary trade.

Based on SEC Form 4 filings from the past 90 days, PHSM insider trading sentiment is currently neutral with an Alignment Score of 63/100. The net insider flow of $12.0K reflects accumulation, with 63% of volume being purchases.

SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like PHASE III MEDICAL INC/DE. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At PHSM, we track all Form 4 filings—currently showing 18 transactions from 7 insiders over 90 days.

A 10b5-1 plan allows PHASE III MEDICAL INC/DE executives to pre-schedule stock sales when they don't possess material non-public information. At PHSM, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at PHSM appears discretionary, making insider signals more meaningful.

You can monitor PHASE III MEDICAL INC/DE (PHSM) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 7 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.

Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. PHASE III MEDICAL INC/DE's current score of 63/100 indicates moderately bullish sentiment suggesting insider confidence. This is calculated from $30.0K in purchases versus $18.0K in sales over 90 days, resulting in a net flow of $12.0K.

SEC Form 4 filings are mandatory reports that PHASE III MEDICAL INC/DE insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At PHSM, the most common type is "A" with 8 occurrences. The most recent Form 4 was filed on Aug 30, 2006 by M. Vaczy Catherine.

Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At PHASE III MEDICAL INC/DE, approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at PHSM represents discretionary decisions with more informational value.